MEDI
Medimmune, Inc.
Biotechnology company focused on innovative therapies and vaccines; acquired by AstraZeneca in 2007 and brand retired in 2019.
CUSIP: 584699102HealthcareUS1 holder
Total Value
$7.08M
Total Shares
261.2K
Net Share Change
+261.2K
Activity
1 buying
Investor
Value
Shares
Weight
Change
